Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Virus validation procedures: practical aspects

P D Minor1

  • 1National Institute for Biological Standards and Control, Potters Bar, Hertfordshire, UK.

Blood Coagulation & Fibrinolysis : an International Journal in Haemostasis and Thrombosis
|July 1, 1995
PubMed
Summary
This summary is machine-generated.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Evaluation of a test for its suitability in the diagnosis of variant Creutzfeldt-Jakob disease.

Vox sanguinis·2013
Same author

Growth and characterization of poliovirus antigen chimeras.

Methods in molecular biology (Clifton, N.J.)·2011
Same author

Reference materials for the evaluation of pre-mortem variant Creutzfeldt-Jakob disease diagnostic assays.

Vox sanguinis·2007
Same author

Absence of detectable measles virus genome sequence in blood of autistic children who have had their MMR vaccination during the routine childhood immunization schedule of UK.

Journal of medical virology·2006
Same author

Assessment of mumps virus growth on various continuous cell lines by virological, immunological, molecular and morphological investigations.

Journal of virological methods·2005
Same author

Virological issues in the use of cell therapies.

Developments in biologicals·2005

Validation studies for biopharmaceutical production processes offer significant assurance of viral safety. Proper execution using relevant model viruses is crucial for minimizing viral transmission risks in biological products.

Area of Science:

  • Biotechnology
  • Pharmaceutical Manufacturing
  • Virology

Background:

  • The Committee for Proprietary Medicinal Products developed guidance for European Union market authorization applications.
  • A specific guidance note addresses the validation of production processes for virus removal or inactivation.

Purpose of the Study:

  • To outline strategies for minimizing viral transmission risk in biological products.
  • To emphasize the importance of validation studies in ensuring viral safety.

Main Methods:

  • Screening source materials for viral contamination.
  • Evaluating the production process's capacity for virus removal or inactivation.
  • Testing the final product for viral contamination.

Main Results:

Related Experiment Videos

  • Validation studies, when properly conducted with appropriate model viruses, provide significant assurance of viral safety.
  • A multi-pronged approach involving source material screening, process evaluation, and final product testing is employed.

Conclusions:

  • Properly executed validation studies are essential for guaranteeing the viral safety of biological products.
  • The strategies outlined are critical for manufacturers seeking market authorization in the European Union.